News

2016 Jun 06

Biomarker confirms efficacy of early drug switch for prostate cancer patients

Metastatic prostate cancer patients respond better to treatment when they switch to different drugs in the absence of an optimal initial response, according to Scott Tagawa, M.D. and Paraskevi Giannakakou, Ph.D. Read more

2016 Jun 05

Young neurosurgeon embraces new technologies to save lives

Profile of Rohan Ramakrishna, M.D., and some of the novel methods he is using to tackle brain tumors. Read more

2016 Jun 05

CASTOR combination is promising treatment for multiple myeloma

Ruben Niesvizky, M.D., comments on a study that tested a new drug combination (daratumumab+bortezomib+dexamethasone) to treat multiple myeloma Read more

2016 Jun 04

Ongoing study assesses effectiveness of BBI-608

Manish Shah, M.D., gives an update on the progress of the BRIGHTER trial to assess a new drug for advanced gastric cancer. Read more

2016 Jun 04

The messenger matters: Oncologists help patients with advanced cancer better understand their illness

Discussing re-staging scan results with oncologists—rather than other care-team members—may lead to a better understanding of late- or end-stage disease in patients with advanced cancers. Read more

Gastrointestinal oncologist Allyson Ocean of the Meyer Cancer Center

2016 Jun 03

Addition of capecitabine to adjuvant chemotherapy extends survival in pancreatic cancer

Allyson Ocean, M.D., comments on a new drug combination for pancreatic cancer patients. Read more

2016 Jun 03

Cantley named as 'Giant of Cancer Care' finalist

Lewis Cantley, Ph.D., has been recognized by OncLive as a finalist for the 'Giants of Cancer Care' award. Read more

2016 Jun 03

How molecular testing guides treatment in AML

Gail Roboz, M.D., discusses the use of molecular genetics to guide leukemia treatment. Read more

2016 Jun 02

Varmus joins International Biomedical Research Alliance Board

Harold Varmus, M.D., joins international effort to promote the careers of young scientists. Read more

2016 Jun 02

Computational method uncovers new potential therapeutic option for difficult-to-treat subtype of prostate cancer

The steroid dexamethasone could potentially deter the growth of a prostate cancer subtype that was previously thought to be difficult to treat with medications, according to research by David Rickman and Olivier Elemento. Read more

Dr Lewis Cantley in his lab at the Meyer Cancer Center of Weill Cornell Medicine

2016 Jun 01

How Philanthropic Support is Driving Groundbreaking Cancer Research

Dr. Cantley discusses the importance of philanthropy in supporting the cancer center Read more

2016 Jun 01

Changing the Cancer Conversation

Ruben Niesvizky, M.D, is featured in Delta's Sky magazine as part of an in-depth article on cancer research Read more

2016 Jun 01

Systems Biology Digs Deep, Aims High

Olivier Elemento, Ph.D., discusses how a systems biology approach benefits cancer research and treatment. Read more

Photo of Christopher Barbieri, M.D., Ph.D.

2016 May 31

SPOP Mutations in Prostate Cancer

Christopher E. Barbieri, M.D., Ph.D., discusses the implications of SPOP mutations in patients with prostate cancer. Read more

2016 May 31

IMMU-132 in patients with urothelial carcinoma

Scott T. Tagawa, M.D., M.S., discusses the antibody-drug conjugate IMMU-132 for the treatment of patients with metastatic platinum-resistant urothelial cancer. Read more

2016 May 31

New scalp cooling system prevents hair loss from chemotherapy

Video segment features oncologist Tessa Cigler, M.D., and breast cancer patient Carolyn Dempsey. Read more

Christopher Mason, Ph.D., receiving the Pershing Sohn Prize

2016 May 26

Ackman dangles meeting with ‘Hamilton’ star for rapper scientist

Christopher Mason, Ph.D. recently rapped while receiving his Pershing Square Sohn Prize. Read more

2016 May 26

Mason to conduct groundbreaking study of antimicrobial resistance in 54 international cities

Christopher Mason, Ph.D., will lead a project to develop a map of 54 cities to show their genetic differences and epigenetic states. Read more

Lung cancer survivor Tom Murphy and daughter Julia

2016 May 25

Superman is 58 and lives in Bronxville

Lung cancer patient Tom Murphy has returned to running after undergoing surgery with Brendon Stiles, M.D. Read more

2016 May 25

Higher dose Herceptin shows no significant impact on survival in gastric cancer

Manish Shah, M.D., discusses the impacts of different dosing levels of Herceptin in HER2-positive gastric cancer Read more

News

Biomarker confirms efficacy of early drug switch for prostate cancer patients

Young neurosurgeon embraces new technologies to save lives

CASTOR combination is promising treatment for multiple myeloma

Ongoing study assesses effectiveness of BBI-608

The messenger matters: Oncologists help patients with advanced cancer better understand their illness

Addition of capecitabine to adjuvant chemotherapy extends survival in pancreatic cancer

Cantley named as 'Giant of Cancer Care' finalist

How molecular testing guides treatment in AML

Varmus joins International Biomedical Research Alliance Board

Computational method uncovers new potential therapeutic option for difficult-to-treat subtype of prostate cancer

How Philanthropic Support is Driving Groundbreaking Cancer Research

Changing the Cancer Conversation

Systems Biology Digs Deep, Aims High

SPOP Mutations in Prostate Cancer

IMMU-132 in patients with urothelial carcinoma

New scalp cooling system prevents hair loss from chemotherapy

Ackman dangles meeting with ‘Hamilton’ star for rapper scientist

Mason to conduct groundbreaking study of antimicrobial resistance in 54 international cities

Superman is 58 and lives in Bronxville

Higher dose Herceptin shows no significant impact on survival in gastric cancer

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters